Quick Answer
Tanke Biosciences Corp reported Earnings Per Share Diluted of $0.24 (loss) per share for the year ending 2011.
- Tanke Biosciences Corp showed a decrease of -170.6% in Earnings Per Share Diluted from 2010 to 2011.
- This data is from Tanke Biosciences Corp's annual report (Form 10-K), filed with the SEC on April 16, 2012.
- XBRL data for this metric is available from 2010 to 2011 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $0.17 (loss) per share | Q3 2011: $0.11 (loss) per share | Q1 2012: $0.05 (loss) per share | Q3 2012: $0.07 per share.
- Historical annual values: Fiscal year 2011: $0.24 (loss) per share | Fiscal year 2010: $0.34 per share.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: